Defendant entity record

L'Oréal USA

Cosmetics conglomerate; lead defendant (with other manufacturers) in the chemical hair relaxer litigation — the fourth-largest active MDL at 11,877 pending cases.

Ticker OR (Euronext) / LRLCY (OTC)Facts verified Jul 19, 2026

The record

Key facts

Fact 01

11,877 — pending cases, 4th-largest active MDL

Source: https://www.jpml.uscourts.gov/

Fact 02

MDL-3060 — N.D. Ill., Judge Mary M. Rowland

Source: https://www.jpml.uscourts.gov/

The entity

Record

The hair relaxer litigation (MDL-3060, Judge Mary M. Rowland, N.D. Illinois) consolidates claims that chemical straightening products caused uterine and other hormone-driven cancers, with filings accelerating after federal researchers published findings linking frequent relaxer use to elevated uterine-cancer risk.

As of July 1, 2026 the docket held 11,877 pending cases — the fourth-largest active MDL in the country — against L'Oréal and other manufacturers. The litigation is in active common discovery; no bellwether verdicts have been returned. Allegations remain allegations until adjudicated.

The claimant population and marketing history give this docket an unusually pointed accountability dimension — products marketed heavily to Black women over decades — which is central to plaintiffs' failure-to-warn theories.

Public-record events

Timeline

Related litigation

Cases

Sources & attribution

Sources cited